Trikatu and Haridra drug effectiveness in treatment of abnormal lipids
Phase 2
Completed
- Conditions
- Health Condition 1: E784- Other hyperlipidemia
- Registration Number
- CTRI/2022/08/044729
- Lead Sponsor
- Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients between age group of 25 â?? 60 years in either sex.
Diagnosed and confirmed cases of Dyslipidemia (Medodushti) on the basis of criteria given by NCEP ATP III
Newly diagnosed case of NIDDM with optimal control Diabetes mellitus
Exclusion Criteria
Patients with age below 25 year and above 60 years.
Patients have medical history of unstable angina, myocardial infarction, heart failure, stroke within 3 months of study, stage 2hypertension,stage 3 hypertension,type I diabetes mellitus, impaired renal function, hypothyroidism, jaundice, hepatitis, chronic infection and other serious diseases.
Pregnancy, lactation and patients having dyslipidemia due to drugs ex. Glucocorticoids, diuretics.
BMI >30Kg/m2
Patients not giving consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in Cholesterol, Triglycerides, LDL and VLDL and Increases in HDLTimepoint: 2 months
- Secondary Outcome Measures
Name Time Method patient breathlessness, excessive sweating, weakness, Snoring e.t.c symptoms will be reduced.Timepoint: 2 month